SEC Tracker
Get the app

Tango Therapeutics TNGX

Tango Therapeutics Reports Second Quarter 2025 Financial Results

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Tango Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Elite Pharmaceuticals ELTP public float $534M, Sep 30, 2025
  2. Iovance Biotherapeutics IOVA public float $535M, Jun 30, 2025
  3. Opko Health OPK public float $540M, Dec 31, 2025
  4. Savara SVRA public float $544M, Jun 30, 2025
  5. Xencor XNCR public float $556M, Jun 30, 2025